REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 2 filers reported holding REPLIMUNE GROUP INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,465,703 | -18.0% | 1,430,025 | +11.3% | 0.01% | -20.0% |
| Q2 2023 | $29,824,541 | +56.9% | 1,284,449 | +19.3% | 0.01% | +66.7% |
| Q1 2023 | $19,010,269 | +96178.9% | 1,076,483 | +48.3% | 0.01% | 0.0% |
| Q4 2022 | $19,745 | -99.8% | 725,888 | +12.1% | 0.01% | +50.0% |
| Q3 2022 | $11,178,000 | +35.2% | 647,356 | +36.8% | 0.00% | +33.3% |
| Q2 2022 | $8,269,000 | +41.4% | 473,056 | +37.4% | 0.00% | +50.0% |
| Q1 2022 | $5,848,000 | -7.2% | 344,397 | +48.1% | 0.00% | 0.0% |
| Q4 2021 | $6,301,000 | +21.2% | 232,477 | +32.6% | 0.00% | 0.0% |
| Q3 2021 | $5,198,000 | +100.2% | 175,360 | +159.6% | 0.00% | +100.0% |
| Q2 2021 | $2,596,000 | +155.0% | 67,552 | +102.8% | 0.00% | – |
| Q1 2021 | $1,018,000 | -19.1% | 33,310 | +1.4% | 0.00% | – |
| Q4 2020 | $1,258,000 | +66.2% | 32,856 | 0.0% | 0.00% | – |
| Q3 2020 | $757,000 | +138.8% | 32,856 | +157.6% | 0.00% | – |
| Q2 2020 | $317,000 | – | 12,755 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |